Democratizing Reproductive Treatments for All

Brent Ragans, president of Ferring Pharmaceuticals US, a specialty biopharmaceutical company involved in various treatment areas, including reproductive medicine and maternal health, explores the stigma surrounding infertility, the challenge of improving patient access to IVF treatment and care, and legislative developments addressing hopeful health coverage and eligibility reform in this area.